At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. The BMS Mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. The TAS is a critical role in our unique customer model to execute the BMS aspiration to be the BioPharma that delivers the most impactful engagement with Health Care Providers (HCPs), driving adoption of new and existing medicines for appropriate patients. The primary role of the TAS is to drive demand for BMS medicines within their portfolio for the appropriate patients. To meet the HCPs expectations, the TAS engages them with a differentiated Customer Experience (Cx) through deeper scientific dialogue on and consistent with label, leveraging new ways of working and CE^3.